PubMed

Thiazolidinediones and risk of repeat target vessel revascularization following percutaneous coronary intervention: a meta-analysis.

Riche DM, Valderrama R, Henyan NN.

Diabetes Care. 2007 Feb;30(2):384-8.PMID: 17259517 [PubMed - indexed for MEDLINE]Related articlesFree article

Thiazolidinediones do not reduce target vessel revascularization in diabetic patients undergoing percutaneous coronary intervention.

Cho L, Lewis BE, Steen LH, Leya FS.

Cardiology. 2005;104(2):97-100. Epub 2005 Jul 11.PMID: 16020949 [PubMed - indexed for MEDLINE]Related articles

Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials.

Geng DF, Jin DM, Wu W, Wang Z, Wang JF.

Atherosclerosis. 2009 Feb;202(2):521-8. Epub 2008 May 28.PMID: 18602105 [PubMed - indexed for MEDLINE]Related articles

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials.

Lago RM, Singh PP, Nesto RW.

Lancet. 2007 Sep 29;370(9593):1129-36. Review.PMID: 17905165 [PubMed - indexed for MEDLINE]Related articles

Drug-eluting stents: a systematic review and economic evaluation.

Hill RA, Boland A, Dickson R, Dündar Y, Haycox A, McLeod C, Mujica Mota R, Walley T, Bagust A.

Health Technol Assess. 2007 Nov;11(46):iii, xi-221. Review.PMID: 17999841 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events.

Starner CI, Schafer JA, Heaton AH, Gleason PP.

J Manag Care Pharm. 2008 Jul-Aug;14(6):523-31.PMID: 18693776 [PubMed - indexed for MEDLINE]Related articlesFree article

Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention.

Biondi-Zoccai GG, Lotrionte M, Anselmino M, Moretti C, Agostoni P, Testa L, Abbate A, Cosgrave J, Laudito A, Trevi GP, Sheiban I.

Am Heart J. 2008 Jun;155(6):1081-9. Epub 2008 Feb 19.PMID: 18513523 [PubMed - indexed for MEDLINE]Related articles

Pioglitazone and the risk of myocardial infarction and other major adverse cardiac events: a meta-analysis of randomized, controlled trials.

Nagajothi N, Adigopula S, Balamuthusamy S, Velazquez-Cecena JL, Raghunathan K, Khraisat A, Singh S, Molnar J, Khosla S, Benatar D.

Am J Ther. 2008 Nov-Dec;15(6):506-11.PMID: 19127132 [PubMed - indexed for MEDLINE]Related articles

A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery.

Jaffery Z, Kowalski M, Weaver WD, Khanal S.

Eur J Cardiothorac Surg. 2007 Apr;31(4):691-7. Epub 2007 Feb 14. Review.PMID: 17300948 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of thiazolidinedione therapy on restenosis after coronary stent implantation: a meta-analysis of randomized controlled trials.

Rosmarakis ES, Falagas ME.

Am Heart J. 2007 Jul;154(1):144-50. Review.PMID: 17584567 [PubMed - indexed for MEDLINE]Related articles

Thiazolidinediones and the risk of edema: a meta-analysis.

Berlie HD, Kalus JS, Jaber LA.

Diabetes Res Clin Pract. 2007 May;76(2):279-89. Epub 2006 Oct 18.PMID: 17055103 [PubMed - indexed for MEDLINE]Related articles

Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.

Singh S, Loke YK, Furberg CD.

JAMA. 2007 Sep 12;298(10):1189-95.PMID: 17848653 [PubMed - indexed for MEDLINE]Related articlesFree article

Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trial.

Brener SJ, Steinhubl SR, Berger PB, Brennan DM, Topol EJ; for the CREDO Investigators.

J Invasive Cardiol. 2007 Jul;19(7):287-90.PMID: 17620671 [PubMed - indexed for MEDLINE]Related articlesFree article

Statins in prevention of repeat revascularization after percutaneous coronary intervention-a meta-analysis of randomized clinical trials.

Zhang ZJ, Cheng Q, Jiang GX, Marroquin OC.

Pharmacol Res. 2009 Nov 13. [Epub ahead of print]PMID: 19922797 [PubMed - as supplied by publisher]Related articles

Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.

Dahabreh IJ, Economopoulos K.

Clin Trials. 2008;5(2):116-20. Erratum in: Clin Trials. 2008;5(5):559. Economopoulos, K [added]. PMID: 18375649 [PubMed - indexed for MEDLINE]Related articles

Peroxisome proliferator-activated receptor gamma agonists for the Prevention of Adverse events following percutaneous coronary Revascularization--results of the PPAR study.

Bhatt DL, Chew DP, Grines C, Mukherjee D, Leesar M, Gilchrist IC, Corbelli JC, Blankenship JC, Eres A, Steinhubl S, Tan WA, Resar JR, AlMahameed A, Abdel-Latif A, Wilson Tang WH, Brennan D, McErlean E, Hazen SL, Topol EJ.

Am Heart J. 2007 Jul;154(1):137-43. Erratum in: Am Heart J. 2007 Aug;154(2):402. Tang, H Wilson [corrected to Wilson Tang, W H]. PMID: 17584566 [PubMed - indexed for MEDLINE]Related articles

[Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials]

Silber S, Herdeg C.

Herz. 2008 Apr;33(3):196-205. Review. German. PMID: 18568314 [PubMed - indexed for MEDLINE]Related articles

Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis.

Mahmud E, Bromberg-Marin G, Palakodeti V, Ang L, Creanga D, Demaria AN.

J Am Coll Cardiol. 2008 Jun 24;51(25):2385-95.PMID: 18565394 [PubMed - indexed for MEDLINE]Related articles

Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.

Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, Hueb WA, Lemos PA, Serruys PW.

Circulation. 2008 Sep 9;118(11):1146-54. Epub 2008 Aug 25.PMID: 18725490 [PubMed - indexed for MEDLINE]Related articlesFree article

The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials.

Sinno MC, Khanal S, Al-Mallah MH, Arida M, Weaver WD.

Am Heart J. 2007 Apr;153(4):579-86.PMID: 17383297 [PubMed - indexed for MEDLINE]Related articles